HUES25 |
Harvard University |
RG-148; DYSTROPHIA MYOTONICA 1 (DM1), affected, 46,XY |
Reproductive Genetics Institute |
RG-153; DYSTROPHIA MYOTONICA 1 (DM1), affected, 46,XX |
Reproductive Genetics Institute |
RG-170; MUSCULAR DYSTROPHY, BECKER TYPE (BMD), affected, 46,XY |
Reproductive Genetics Institute |
RG-186; HUNTINGTON DISEASE (HD), affected, 46,XX |
Reproductive Genetics Institute |
RG-194; HUNTINGTON DISEASE (HD), affected, 46,XY |
Reproductive Genetics Institute |
RG-233; HEMOGLOBIN BETA LOCUS (HBB), affected (HbS/HbS - sickle cell anemia), 46,XX |
Reproductive Genetics Institute |
RG-245; EMERY-DREIFUSS MUSCULAR DYSTROPHY, X-LINKED (EDMD), carrier, 47,XXY |
Reproductive Genetics Institute |
RG-246; EMERY-DREIFUSS MUSCULAR DYSTROPHY, X-LINKED (EDMD), affected, 46,XY |
Reproductive Genetics Institute |
RG-271; TORSION DYSTONIA 1 ( DYT1), AUTOSOMAL DOMINANT, affected (N/GAG del), 46,XY |
Reproductive Genetics Institute |
RG-283; MUSCULAR DYSTROPHY, DUCHENNE TYPE (DMD), affected, 46,XY |
Reproductive Genetics Institute |
RG-288; CYSTIC FIBROSIS (CF), affected (deltaF508/deltaF508), 46,XY |
Reproductive Genetics Institute |
RG-289; CYSTIC FIBROSIS (CF), affected (deltaF508/deltaF508), 46,XX |
Reproductive Genetics Institute |
RG-301; MUSCULAR DYSTROPHY, DUCHENNE TYPE( DMD) affected, 46,XY |
Reproductive Genetics Institute |
RG-302; MUSCULAR DYSTROPHY, DUCHENNE TYPE (DMD), carrier, 46,XX |
Reproductive Genetics Institute |
RG-315; NEUROFIBROMATOSIS, TYPE I (NF1), affected (R19 47X/N), 46,XY |
Reproductive Genetics Institute |
RG-316; TUBEROUS SCLEROSIS, TYPE 1(TSC1), affected (N/IVS7+1 G-A) |
Reproductive Genetics Institute |
RG-320; TUBEROUS SCLEROSIS, TYPE 1(TSC1), affected (N/IVS7+1 G-A) |
Reproductive Genetics Institute |
RG-326; POPLITEAL PTERYGIUM SYNDROME (PPS),affected (R84H/N), 46,XY |
Reproductive Genetics Institute |
RG-328; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1A( FSHD), affected, 46,XY |
Reproductive Genetics Institute |
RG-330; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1A (FSHD), affected, 46,XY |
Reproductive Genetics Institute |
RG-333; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1A (FSHD), affected, 46,XX |
Reproductive Genetics Institute |
RG-356; HEMOGLOBIN ALPHA LOCUS (HBA), affected (-alpha /--), 46,XX |
Reproductive Genetics Institute |
RG-357; EMERY-DREIFUSS MUSCULAR DYSTROPHY, X-LINKED (EDMD), affected, 46,XY |
Reproductive Genetics Institute |
RG-358; EMERY-DREIFUSS MUSCULAR DYSTROPHY, X-LINKED (EDMD), affected, 46,XY |
Reproductive Genetics Institute |
RG-401; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1A (FSHD), affected, 46,XX |
Reproductive Genetics Institute |
RG-402; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1A (FSHD), affected, 46,XX |
Reproductive Genetics Institute |
RG-403; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1A (FSHD), affected |
Reproductive Genetics Institute |
RG-404; SPINAL MUSCULAR ATROPHY, TYPE I (SMA1), affected, 46,XY |
Reproductive Genetics Institute |
RG-406; TORSION DYSTONIA 1, AUTOSOMAL DOMINANT (DYT1), affected (N/GAG del) |
Reproductive Genetics Institute |
RG-413; BREAST CANCER, FAMILIAL (BRCA2),affected (N/IVS7 GT del) & MULTIPLE ENDOCRINE NEOPLASIA, TYPE I (MEN1), affected (N/3036 4bp del) |
Reproductive Genetics Institute |
RG-414; MULTIPLE ENDOCRINE NEOPLASIA, TYPE I ( MEN1), affected (N/3036 4bp del) |
Reproductive Genetics Institute |
RG-415; HUNTINGTON DISEASE (HD), affected |
Reproductive Genetics Institute |
RG-416; CYSTIC FIBROSIS (CF), affected (deltaF508/1717-1 G-A) |
Reproductive Genetics Institute |
RG-417; CYSTIC FIBROSIS (CF), affected (deltaF508/1717-1 G-A) |
Reproductive Genetics Institute |
RG-418; HEMOGLOBIN BETA LOCUS (HBB), affected (cd8+G /619del) |
Reproductive Genetics Institute |
RG-420; HEMOGLOBIN BETA LOCUS (HBB), affected (cd8+G/619del) |
Reproductive Genetics Institute |
RG-422; CYSTIC FIBROSIS (CF), affected (N1303K/deltaF508) |
Reproductive Genetics Institute |
RG-423; CYSTIC FIBROSIS (CF), carrier (N/deltaF508) |
Reproductive Genetics Institute |
RG-424; MULTIPLE ENDOCRINE NEOPLASIA, TYPE 2 (MEN2B), affected (M918T/N) |
Reproductive Genetics Institute |
RG-426; PELIZAEUS-MERZBACHER DISEASE (PMLD), affected |
Reproductive Genetics Institute |
RG-428; TUBEROUS SCLEROSIS, TYPE 1 (TSC1), affected (N/IVS7+1 G-A) |
Reproductive Genetics Institute |
RG-222 |
Reproductive Genetics Institute |
RG-230 |
Reproductive Genetics Institute |
RG-249 |
Reproductive Genetics Institute |
RG-308 |
Reproductive Genetics Institute |
RG-313 |
Reproductive Genetics Institute |
RG-399; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1A (FSHD), affected, 46,XX |
Reproductive Genetics Institute |
RNJ7 |
Reprogenetics, LLC |
CM-2 |
Children's Memorial Hospital |
CM-6 |
Children's Memorial Hospital |
CM-7 |
Children's Memorial Hospital |
FY-hES-1 |
THE THIRD AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL COLLEGE |
FY-hES-3 |
THE THIRD AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL COLLEGE |
FY-hES-5 |
THE THIRD AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL COLLEGE |
FY-hES-7 |
THE THIRD AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL COLLEGE |
FY-hES-8 |
THE THIRD AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL COLLEGE |
FY-3PN |
THE THIRD AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL COLLEGE |
CR1 |
The University of Texas Health Science Center at Houston |
CR2 |
The University of Texas Health Science Center at Houston |
K117 |
VistaGen Therapeutics, Inc. |
J618 |
VistaGen Therapeutics, Inc. |
J713 |
VistaGen Therapeutics, Inc. |
RNJ11 |
Reprogenetics, LLC |
RNJ12 |
Reprogenetics, LLC |
CSC14 (not approved) |
California Stem Cell, Inc. |
Social Media Links